GSK3B and prostate carcinoma: However, Vandooren et al. [15] reported that glycogen synthase kinase 3 beta (GSK-3β) stabilizes Cadherin-11 mRNA expression by β-catenin-independent pathway in prostate cancer and breast cancer cells.